SEC Form 8-K Summary
Registrant: Brilliant Acquisition Corporation, not T3 Defense Inc. The filing reports events beginning June 21, 2023, with a related press release issued June 23, 2023. Brilliant is a special purpose acquisition company pursuing a proposed business combination with Nukkleus.
Business Context and Reporting Period
The filing was submitted under Items 1.01, 2.03, 7.01, and 9.01. It concerns financing to extend Brilliant’s deadline to complete its initial business combination and disclosures regarding the proposed transaction with Nukkleus and a merger subsidiary.
Financial Metrics and Liquidity
| Item | Reported information |
|---|---|
| New financing | Brilliant issued an unsecured, non-interest-bearing promissory note for $32,450 to its sponsor, Nisun Investment Holding Limited, on June 21, 2023. |
| Maturity | The note matures upon closing of the initial business combination. |
| Repayment if no transaction | If no business combination is completed, repayment is limited to amounts remaining outside Brilliant’s trust account, if any. |
| Use of proceeds | Proceeds were deposited into the trust account in connection with extending the business-combination completion period. |
| Revenue, profit, cash flow and margins | The filing does not provide current-period revenue, profitability, cash-flow, margin, or operating-performance metrics. |
Material Changes
- Brilliant extended its business-combination deadline by one month, to July 23, 2023.
- The sponsor financing increased obligations by $32,450, although the note is unsecured and bears no interest.
- The filing does not provide a prior comparable-period financial statement or quantified operating changes.
Guidance, Outlook, Risks and Unusual Items
- Completion of the proposed Nukkleus transaction remains subject to shareholder approvals, satisfaction of the minimum trust-account condition after redemptions, regulatory approvals, and other closing conditions.
- The transaction may not close by July 23, 2023, and failure to complete a transaction or obtain another extension could materially affect Brilliant securities and repayment prospects for the note.
- Additional disclosed risks include potential litigation, Nasdaq listing risks, redemption-related funding constraints, regulatory and industry changes, transaction-related disruption, employee-retention challenges, and uncertainty regarding post-closing business plans.
- The proposed transaction materials, including the Form S-4 registration statement and proxy statement/prospectus, should be reviewed for transaction terms, dilution, ownership, redemption mechanics, and risk factors.
- The Item 7.01 press release is furnished rather than filed for purposes of Section 18 of the Exchange Act, except where expressly incorporated by reference.
Investor Verification Checklist
- Verify whether the proposed Nukkleus business combination closed, was further extended, or was terminated after July 23, 2023.
- Confirm the trust-account balance, shareholder redemptions, and whether the minimum trust-account condition was satisfied.
- Review the full promissory note for repayment terms and any amendments or subsequent sponsor financing.
- Review the Form S-4 and definitive proxy materials for transaction consideration, dilution, approvals, and regulatory conditions.
- Confirm Brilliant’s subsequent SEC filings for liquidity, Nasdaq listing status, and any liquidation or wind-down actions.